Scopa James Paul 4
4 · Aligos Therapeutics, Inc. · Filed Oct 27, 2023
Insider Transaction Report
Form 4
Scopa James Paul
Director
Transactions
- Award
Warrant (Right to Buy)
2023-10-25$0.13/sh+91,541$11,443→ 91,541 totalExercise: $0.76From: 2023-10-25Exp: 2030-10-25→ Common Stock (91,541 underlying) - Award
Common Stock
2023-10-25$0.76/sh+183,083$138,557→ 183,083 total